Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

I nternational S ociety of N europathology‐ H aarlem
Louis, David N. , Burger, Peter C. , Ellison, David W. , Reifenberger, Guido , Deimling, Andreas von , Aldape, Kenneth , Collins, V. Peter , Figarella‐Branger, Dominique , Fuller, Gregory N. , Giangaspero, Felice , Hawkins, Cynthia , Kleihues, Paul, Korshunov, Andrey , Lopes, M. Beatriz S. , Ng, Ho‐Keung , Ohgaki, Hiroko, Paulus, Werner , Pietsch, Torsten , Rosenblum, Marc K. , Söylemezoğlu, Figen , Wiestler, Otmar D., Wesseling, Pieter , Perry, Arie , Brat, Daniel J. , Eberhart, Charles G. , Giannini, Caterina , Kros, Johan M. , Rushing, Elisabeth Jane , Wesseling, Pieter , von Deimling, Andreas

Brain Pathology | July 2, 2014 | Volume: 24 | Issue: 5 | Pages: 429-435

10.1111/bpa.12171 | PMID 24990071 Get It

Abstract Major discoveries in the biology of nervous system tumors have raised the question of how non‐histological data such as molecular information can be incorporated into the next W orld H ealth O rganization ( WHO ) classification of central nervous system tumors. To address this question, a meeting of neuropathologists with expertise in molecular diagnosis was held in H aarlem, the N etherlands, under the sponsorship of the I nternational S ociety of N europathology ( ISN ). Prior to the meeting, participants solicited input from clinical colleagues in diverse neuro‐oncological specialties. The present “white paper” catalogs the recommendations of the meeting, at which a consensus was reached that incorporation of molecular information into the next WHO classification should follow a set of provided “ ISN ‐ H aarlem” guidelines. Salient recommendations include that (i) diagnostic entities should be defined as narrowly as possible to optimize interobserver reproducibility, clinicopathological predictions and therapeutic planning; (ii) diagnoses should be “layered” with histologic classification, WHO grade and molecular information listed below an “integrated diagnosis”; (iii) determinations should be made for each tumor entity as to whether molecular information is required, suggested or not needed for its definition; (iv) some pediatric entities should be separated from their adult counterparts; (v) input for guiding decisions regarding tumor classification should be solicited from experts in complementary disciplines of neuro‐oncology; and (iv) entity‐specific molecular testing and reporting formats should be followed in diagnostic reports. It is hoped that these guidelines will facilitate the forthcoming update of the fourth edition of the WHO classification of central nervous system tumors.
Relationship between HgbA1c and Myocardial Blood Flow Reserve in Patients with Type 2 Diabetes Mellitus: Noninvasive Assessment Using Real-Time Myocardial Perfusion Echocardiography
Huang, Runqing, Nhola, Lara F., Abdelmoneim, Sahar S. , Mulvagh, Sharon L.

Journal of Diabetes Research | July 2, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-8

10.1155/2014/243518 | PMID 25097860 Get It

To study the relationship between glycosylated hemoglobin (HgbA1c) and myocardial perfusion in type 2 diabetes mellitus (T2DM) patients, we prospectively enrolled 24 patients with known or suspected coronary artery disease (CAD) who underwent adenosine stress by real-time myocardial perfusion echocardiography (RTMPE). HgbA1c was measured at time of RTMPE. Microbubble velocity (β min−1), myocardial blood flow (MBF, mL/min/g), and myocardial blood flow reserve (MBFR) were quantified. Quantitative MCE analysis was feasible in all patients (272/384 segments, 71%). Those with HgbA1c > 7.1% had significantly lowerβreserveand MBFR than those with HgbA1c ≤ 7.1%(P<0.05). In patients with suspected CAD, there was a significant inverse correlation between MBFR and HgbA1c (r=-0.279,P=0.01); however, in those with known CAD, this relationship was not significant (r=-0.117,P=0.129). Using a MBFR cutoff value > 2 as normal, HgbA1c > 7.1% significantly increased the risk for abnormal MBFR, (adjusted odds ratio: 1.92, 95% CI: 1.12–3.35,P=0.02). Optimal glycemic control is associated with preservation of MBFR as determined by RTMPE, in T2DM patients at risk for CAD.
Destruction of DDIT3/CHOP Protein by Wild-Type SPOP but Not Prostate Cancer-Associated Mutants
Zhang, Pingzhao , Gao, Kun , Tang, Yan , Jin, Xiaofeng , Yu, Hongxiu , Wang, Huan , Zhang, Yuanyuan , Wang, Dejie , Yu, Long , Jian, An , Huang, Haojie , Wang, Chenji

Human Mutation | July 2, 2014 | Volume: 35 | Issue: 9 | Pages: 1142-1151

10.1002/humu.22614 | PMID 24990631 Get It

Antibody-mediated rejection despite inhibition of terminal complement
Bentall, Andrew , Tyan, Dolly B., Sequeira, Flavia, Everly, Matthew J. , Gandhi, Manish J. , Cornell, Lynn D. , Henderson, Nicole , Raghavaiah, Suresh , Dean, Patrick G. , Stegall, Mark D. , Li, Han , Winters, Jeffrey L. , Stegall, Mark D , Bentall, Andrew , Cornell, Lynn

Transplant International | July 2, 2014 | Volume: 27 | Issue: 12 | Pages: 1235-1243

10.1111/tri.12396 | PMID 24990476 Get It

How should we “empower” cancer patients?
Kaur, Judith S.

Cancer | July 2, 2014 | Volume: 120 | Issue: 20 | Pages: 3108-3110

10.1002/cncr.28852 | PMID 24989133 Get It

Validated measures of empowerment for cancer patients will be very useful for program interventions. In this editorial, the author reviews the 2 articles in this issue that used the Health Education Information Questionnaire and suggests other important populations to study.
Operational Diagnostic Criteria for Chronic Migraine: Expert Opinion
Silberstein, Stephen D., Lipton, Richard B. , Dodick, David W.

Headache: The Journal of Head and Face Pain | July 2, 2014 | Volume: 54 | Issue: 7 | Pages: 1258-1266

10.1111/head.12407 | PMID 24990187 Get It

Objective The prevalence, disability, progression, and treatment needs associated with chronic migraine ( CM ) mandate epidemiological, clinical, and basic research to better understand the clinical course of this disorder and to facilitate development of more effective therapies. Such efforts have been significantly impeded by lack of agreement within the headache specialist community of the most appropriate diagnostic criteria for CM . Methods This paper reviews the pertinent nosological literature and extensive field testing already performed. Results We recommend that the I nternational C lassification of H eadache D isorders‐3β criteria for CM be modified. We would remove the need for 5 prior migraine attacks and would replace “Headache considered by patient to be onset migraine and relieved by a triptan or an ergotamine derivative” with “criteria A and B for 1.5 probable migraine .” Conclusions The proposed criteria are guided by the aims of accurately characterizing patients with migraine who develop primary chronic daily headache, reflecting the large numbers of patients with CM in clinical practice, and facilitating research into a disorder that is an academic and clinical priority.
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
Malik, Mohsin, Litzow, Mark R. , Patnaik, Mrinal M. , Murad, M. Hassan , Hashmi, Shahrukh K. , Malik, Mohsin Ilyas, Hogan, William, Murad, Mohammad Hassan, Winters, Jeffrey L. , Hashmi, Shahrukh, Hogan, William J. , Prokop, Larry J. , Murad, M Hassan

Blood Research | July 2, 2014 | Volume: 49 | Issue: 2 | Pages: 100

10.5045/br.2014.49.2.100 | PMID 25025011 Get It

High-Sensitivity Troponin I and Amino-Terminal Pro–B-Type Natriuretic Peptide Predict Heart Failure and Mortality in the General Population
AbouEzzeddine, Omar F. , Mehta, Ramila A. , Rodeheffer, Richard J. , Redfield, Margaret M. , Burnett, John C. , Jaffe, Allan S. , McKie, Paul M. , Scott, Christopher G. , Jaffe, Allan S. , AbouEzzeddine, Omar F

Clinical Chemistry | July 2, 2014 | Volume: 60 | Issue: 9 | Pages: 1225-1233

10.1373/clinchem.2014.222778 | PMID 24987112 Get It

Abstract INTRODUCTION High-sensitivity cardiac troponin assays have potent prognostic value in stable cardiovascular disease cohorts. Our objective was to assess the prognostic utility of a novel cardiac troponin I (cTnI) high-sensitivity assay, independently and in combination with amino-terminal pro–B-type natriuretic peptide (NT-proBNP), for the future development of heart failure and mortality in the general community. METHODS A well-characterized community-based cohort of 2042 participants underwent clinical assessment and echocardiographic evaluation. Baseline measurements of cTnI with a high-sensitivity assay and NT-proBNP were obtained in 1843 individuals. Participants were followed for new-onset heart failure and mortality with median (25th, 75th percentile) follow-up of 10.7 (7.9, 11.6) and 12.1 (10.4, 13.0) years, respectively. RESULTS When measured with a high-sensitivity assay, cTnI greater than the sex-specific 80th percentile was independently predictive of heart failure [hazard ratio 2.56 (95% confidence interval 1.88–3.50), P &lt; 0.001] and mortality [1.91(1.49–2.46), P &lt; 0.001] beyond conventional risk factors in this community-based cohort, with significant increases in the net reclassification improvement for heart failure. The prognostic utility of cTnI measured with a high-sensitivity assay goes beyond NT-proBNP, yet our data suggest that these 2 assays are complementary and most beneficial when evaluated together in identifying at-risk individuals in the community. CONCLUSIONS Our findings lay the foundation for prospective studies aimed at identification of individuals at high risk by use of a multimarker approach, followed by aggressive prevention strategies to prevent subsequent heart failure.
Abnormal Movements in Children With Migraine
Youssef, Paul E., Mack, Kenneth J.

Journal of Child Neurology | July 2, 2014 | Volume: 30 | Issue: 3 | Pages: 285-288

10.1177/0883073814538499 | PMID 24985753 Get It

The cause and treatment of functional movement disorders and nonepileptic spells in children is poorly understood, and an association with migraine has not previously been reported. We retrospectively reviewed children diagnosed with chronic or episodic migraine at our institution from 2006 to 2013 to determine the proportion with nonorganic movement disorders, their phenomenology, provoking factors, and natural history. Thirty-two patients were identified, representing 4.3% of patients with chronic migraine and 0.9% of patients with episodic migraine. Twenty-four of the 32 (75%) had chronic migraine, whereas 8 (25%) had episodic migraine. Nonepileptic spells was the most common phenomenon in both cohorts, followed by tremor and functional gait disorders. Severe migraine attacks preceded these movements in the majority of patients. With appropriate migraine therapy, significant reduction or resolution of these movements was reported. We conclude that nonorganic movement disorders are observed in pediatric migraine, are more prevalent among chronic migraineurs, and can resolve with improved pain control.
Thiazide Diuretic Prophylaxis for Kidney Stones and the Risk of Diabetes Mellitus
Singh, Prince , Knoedler, John, Krambeck, Amy E. , Bergstralh, Eric J., Knoedler, John J., Lieske, John C. , Rule, Andrew D.

Journal of Urology | July 1, 2014 | Volume: 192 | Issue: 6 | Pages: 1700-1704

10.1016/j.juro.2014.06.078 | PMID 24992333 Get It